Reviewing TruBridge (NASDAQ:TBRG) and HeartSciences (NASDAQ:HSCS)

TruBridge (NASDAQ:TBRG) and HeartSciences (NASDAQ:HSCS) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, risk, earnings, valuation and analyst recommendations.

Profitability

This table compares TruBridge and HeartSciences’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
TruBridge	0.92%	18.75%	8.32%
HeartSciences	N/A	-333.50%	-140.18%

Institutional & Insider Ownership

88.6% of TruBridge shares are held by institutional investors. Comparatively, 17.2% of HeartSciences shares are held by institutional investors. 10.7% of TruBridge shares are held by insiders. Comparatively, 4.9% of HeartSciences shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a summary of recent recommendations for TruBridge and HeartSciences, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TruBridge	0	8	0	0	2.00
HeartSciences	1	0	1	0	2.00

TruBridge presently has a consensus price target of $23.95, indicating a potential downside of 8.31%. HeartSciences has a consensus price target of $8.00, indicating a potential upside of 323.28%. Given HeartSciences’ higher probable upside, analysts plainly believe HeartSciences is more favorable than TruBridge.

Earnings & Valuation

This table compares TruBridge and HeartSciences”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TruBridge	$346.84 million	1.13	$4.21 million	$0.20	130.60
HeartSciences	N/A	N/A	-$8.77 million	($4.94)	-0.38

TruBridge has higher revenue and earnings than HeartSciences. HeartSciences is trading at a lower price-to-earnings ratio than TruBridge, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

TruBridge has a beta of 1.28, indicating that its share price is 28% more volatile than the S&P 500. Comparatively, HeartSciences has a beta of 1.96, indicating that its share price is 96% more volatile than the S&P 500.

Summary

TruBridge beats HeartSciences on 9 of the 12 factors compared between the two stocks.

About TruBridge

TruBridge, Inc. provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence. The company provides acute care solutions and related services for community hospitals, and physician clinics; and patient engagement and empowerment technology solutions to improve patient outcomes and engagement strategies with care providers. In addition, it offers patient liability estimates eligibility verification, claim scrubbing and submission, remittance management, denial/audit management, and contract management; and offers RCM services, such as accounts receivable management, private pay service, medical coding, revenue cycle consulting, and other additional insurance and patient billing services. Further, it offers consulting and business management services; managed IT services; encoder solutions; patient management; financial accounting; clinical; patient care; and enterprise applications. Additionally, it offers TruBridge HER platform, including total system support, national client conference, continuing education, software releases, hardware replacement, cloud electronic health record, forms and supplies, and public cloud infrastructure services; post-acute care software systems, and support and maintenance services; and InstantPHR, an interactive portal and CHBase which funnels data from multiple sources into one platform. The company was formerly known as Computer Programs and Systems, Inc. and changed its name to TruBridge, Inc. in March 2024. TruBridge, Inc. was founded in 1979 and is headquartered in Mobile, Alabama.

About HeartSciences

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.